the most promising is tissue-type plasminogen activator ( t-pa ) , which is being evaluated in a number of large multicenter trials , including the national heart , lung , and blood institute 's thrombolysis in myocardial infarction ( timi ) trial .
C0018787
heart
C0027051
myocardial infarction